Nuveen Churchill Direct Lending Corp. current report, 31 March 2022

Business Context and Reporting Period

Nuveen Churchill Direct Lending Corp. filed a Form 8-K reporting that its wholly owned subsidiary, Nuveen Churchill BDC SPV I, LLC, entered into a second amendment to its loan and security agreement on March 31, 2022. The report was signed on April 5, 2022.

Material Financing Terms

  • Maximum facility amount: Increased from $275 million to $350 million.
  • Reinvestment period: Extended from October 28, 2023 to March 31, 2025.
  • Maturity date: Extended from October 28, 2025 to March 31, 2027.
  • Interest rate: Changed to SOFR plus 2.20%.
  • Collateral: Advances are secured by a pool of broadly syndicated and middle-market loans, subject to specified eligibility criteria and advance rates.
  • Asset coverage requirement: The Company must maintain an asset coverage ratio of at least 1.50:1.00.
  • Prepayment and reborrowing: Advances may be prepaid and reborrowed during the reinvestment period.
  • Early facility reduction fee: Termination or reduction of the facility before the first anniversary of the amendment, subject to exceptions, generally incurs a 1% commitment reduction fee.

Financial Performance and Liquidity

The filing does not provide revenue, profit, cash flow, margin, debt balance, liquidity balance, or other operating performance metrics. It does increase the Company’s available secured financing capacity by $75 million and extends the financing facility’s reinvestment and maturity periods.

Material Changes, Outlook, and Risks

  • The amendment materially increases borrowing capacity and extends the facility’s duration, supporting continued portfolio investment and refinancing flexibility.
  • The revised interest rate exposes borrowing costs to changes in SOFR.
  • The 1.50:1.00 asset coverage covenant may constrain borrowing or require portfolio actions if asset values decline.
  • Collateral eligibility, advance rates, covenant compliance, and the early reduction fee could affect the Company’s financing flexibility.
  • The filing provides no formal earnings guidance, portfolio outlook, management forecast, contingencies, or unusual accounting items.

Key Facts for Investor Verification

  • Confirm the final facility size, reinvestment period, maturity date, and SOFR spread in Exhibit 10.1.
  • Review the amendment for detailed eligibility criteria, advance rates, covenants, events of default, and other borrowing restrictions.
  • Assess the Company’s actual borrowings and unused capacity under the amended facility in subsequent periodic filings.
  • Monitor SOFR movements and their effect on interest expense.
  • Verify ongoing compliance with the 1.50:1.00 asset coverage requirement.